Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design

J Autism Dev Disord. 1999 Apr;29(2):167-9. doi: 10.1023/a:1023000929040.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / complications*
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Autistic Disorder / complications*
  • Autistic Disorder / drug therapy
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Interpersonal Relations
  • Male
  • Naltrexone / therapeutic use*
  • Social Adjustment

Substances

  • Naltrexone